未登录 分享 收藏
分享 收藏
Prevalence by therapy line and incidence of breast cancer brain metastases in 18 075 patients 按治疗方案分层的乳腺癌脑转移发生率及发病率(基于18 075例患者) Sammons, Sarah L.; Sanglier, Thibaut; Leone, Jose Pablo; Erick, Timothy K.; Lambert, Peter; Montemurro, Filippo; Poppe, Raf; Restuccia, Eleonora; Tolaney, Sara M.; Lin, Nancy U. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Interim Analysis Results from a European Disease Registry Study Aimed to Prospectively Observe Treatment Patterns and Outcomes in Patients with HER2+Unresectable Locally Advanced or Metastatic Breast Cancer Balic, Marija; Costa, Luis; Ojaimi, Joseline; Oprean, Cristina Marinela; Coelho, Jose L. Passos; Pazos, Isabel; Puglisi, Fabio; Sanglier, Thibaut; Scandurra, Giuseppa; Schenker, Michael; Wahyudi, Laurentia A.; Zhbantov, Georgi; Timcheva, Constanta 分享 收藏
分享 收藏
Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience 真实世界的无进展生存期 (rwPFS) 和下一线治疗时间 (TTNT) 作为转移性乳腺癌生存的中间终点: 真实世界的经验 Labaki, C.; Bakouny, Z.; Sanglier, T.; Schmidt, A.; Shim, J.; Braun, D. A.; Bouquet, F.; Joyce, M.; Xie, W.; Tolaney, S. M.; Choueiri, T. K. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏